Author: digi

Dosage Form and Packaging Interaction: GMP Controls for Extractables and Leachables Step-by-Step GMP Controls for Extractables and Leachables in Dosage Form and Packaging Interactions The integrity of pharmaceutical dosage forms is critically dependent on the appropriate selection and qualification of packaging systems. Extractables and leachables (E&L) represent a key risk area where packaging materials may…

Read More “Dosage Form and Packaging Interaction: GMP Controls for Extractables and Leachables” »

Dosage Form and Packaging Interaction: GMP Controls for Extractables and Leachables Implementing GMP Controls for Extractables and Leachables Across Dosage Forms In pharmaceutical manufacturing, the interaction between dosage form and packaging materials presents a critical quality and safety consideration, especially regarding extractables and leachables (E&L). Regulatory agencies in the US, UK, and EU demand stringent…

Read More “Dosage Form and Packaging Interaction: GMP Controls for Extractables and Leachables” »

GMP for Oral Care Products Manufactured in Pharma Facilities Good Manufacturing Practice for Oral Care Products: A Dosage-Form Approach for Pharmaceutical Facilities Manufacturing oral care products within pharmaceutical facilities requires adherence to stringent Good Manufacturing Practices (GMP) tailored for the unique challenges of these dosage forms. Whether producing solid oral products like toothpaste pellets or…

Read More “GMP for Oral Care Products Manufactured in Pharma Facilities” »

Veterinary Dosage Forms Manufactured Under Human GMP: Alignment and Gaps Veterinary Dosage Forms Manufactured Under Human GMP: Alignment and Gaps The manufacturing of veterinary dosage forms under human GMP standards presents a complex intersection of regulatory expectations and practical requirements. This article provides a detailed step-by-step tutorial for pharma professionals, clinical operations, and regulatory affairs…

Read More “Veterinary Dosage Forms Manufactured Under Human GMP: Alignment and Gaps” »

GMP for Orphan Drug Dosage Forms with Very Small Batch Sizes Good Manufacturing Practice for Orphan Drug Dosage Forms with Very Small Batch Sizes: A Step-by-Step Tutorial Manufacturing orphan drugs—medicinal products intended to treat rare diseases—poses significant challenges, particularly when dosage forms involve very small batch sizes. Achieving compliance with Good Manufacturing Practice (GMP) requirements…

Read More “GMP for Orphan Drug Dosage Forms with Very Small Batch Sizes” »

Dosage-Form Specific Hold Time Studies: From Bulk to Final Pack Comprehensive Step-by-Step Guide on Dosage-Form Specific Hold Time Studies: From Bulk to Final Pack Hold time studies are a critical component of pharmaceutical GMP compliance, ensuring product quality and stability throughout manufacturing and packaging processes. The specific requirements and challenges for hold time studies depend…

Read More “Dosage-Form Specific Hold Time Studies: From Bulk to Final Pack” »

Cleaning Validation Challenges in Multi-Dosage, Multi-Product Facilities Cleaning Validation Challenges in Multi-Dosage, Multi-Product Facilities: A Practical GMP Guide Manufacturing pharmaceutical products in facilities that handle multiple dosage forms such as solid oral tablets, parenteral injectables, and topical formulations inherently involves complex cleaning and cross-contamination control challenges. These challenges significantly impact Good Manufacturing Practice (GMP) compliance,…

Read More “Cleaning Validation Challenges in Multi-Dosage, Multi-Product Facilities” »

Ready-to-Administer and Ready-to-Use Products: GMP Expectations GMP Compliance for Ready-to-Administer and Ready-to-Use Products: A Step-by-Step Tutorial Manufacturers of pharmaceutical products are increasingly focused on delivering ready-to-administer (RTA) and ready-to-use (RTU) dosage forms, which simplify clinical and hospital workflows by minimizing preparation steps. Ensuring robust Good Manufacturing Practice (GMP) compliance for these products requires detailed attention…

Read More “Ready-to-Administer and Ready-to-Use Products: GMP Expectations” »

GMP for Reconstitution Devices and Kits: Usability and Sterility Concerns Ensuring GMP Compliance for Reconstitution Devices and Kits: Addressing Usability and Sterility in Dosage Forms Reconstitution devices and kits play a critical role in the delivery of certain pharmaceutical dosage forms, particularly for parenteral administrations where the drug product is supplied as a solid or…

Read More “GMP for Reconstitution Devices and Kits: Usability and Sterility Concerns” »

Multi-Chamber Bags and Dual-Component Systems: GMP for Mixing and Activation GMP Compliance for Multi-Chamber Bags and Dual-Component Systems: A Step-by-Step Guide Multi-chamber bags (MCBs) and dual-component systems are increasingly utilized in pharmaceutical manufacturing to enable flexible, stable, and safe drug delivery, particularly for parenteral and combination products. These dosage forms combine sterile injectables and liquid…

Read More “Multi-Chamber Bags and Dual-Component Systems: GMP for Mixing and Activation” »